A new method for engineering natural killer cells could make cancer immunotherapy more efficient, scalable, and affordable, potentially reshaping how these treatments are produced.

Physician-researchers with City of Hope have developed a way to add features to T cells to help them overcome mechanisms of chimeric antigen receptor (CAR) T cell therapy resistance. Their new system ...

Four biomedical innovators — Carl June, Bruce Levine, Isabelle Rivière, and Michel Sadelain — have been jointly awarded the 2025 Richard N. Merkin Prize in Biomedical Technology for developing ...

CHAPEL HILL, N.C.--(BUSINESS WIRE)--iOrganBio today announced its launch from stealth with $2 million in funding to transform how human cells are made. The round was led by First Star Ventures along ...

Researchers have found a way to reprogram disease evolution and design tumors that are easier to treat. They created a modular genetic circuit that turns cancer cells into a 'Trojan horse,' causing ...

Researchers at the National University of Singapore (NUS) have developed a scalable, non-viral technology that efficiently delivers genetic material into human immune cells. The platform, called ...

Poly(N-isopropylacrylamide) (PNIPAM) hydrogel undergoes significant but precise changes in size between 20°C and 40°C, making it an excellent candidate for use in variable-size deterministic lateral ...

LOS ANGELES--(BUSINESS WIRE)--Physician-researchers with City of Hope ®, one of the largest cancer research and treatment organizations in the United States with its National Medical Center named Top ...

Scientists haven’t had a precise way to arrange and study surface-bound extracellular vesicles and particles (EVPs) as they guide cell behavior. Researchers developed LEVA, which uses patterned ...

Viral membrane proteins are the proteins of choice in vaccines but are difficult to produce quickly and reliably for use in vaccines, limiting rapid response during emerging outbreaks. Researchers ...